Nagasaki, Japan

Katsuyuki Yui

This inventor holds 1 USPTO granted patent. Top assignees: Hamamatsu University School of Medicine, Kyushu University, Nagasaki University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuyuki Yui. Retrieved from https://idiyas.com/inventor/katsuyuki-yui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katsuyuki Yui: Innovator in Drug Delivery Systems

Introduction

Katsuyuki Yui is a prominent inventor based in Nagasaki, Japan. He has made significant contributions to the field of drug delivery systems, particularly through his innovative patent that enhances the efficacy of antigen and drug delivery.

Latest Patents

Katsuyuki Yui holds a patent for a "Composite body for antigen or drug delivery." This invention provides a complex that includes an antigen or drug combined with a cationic molecule, encapsulated by an anionic molecule. The resulting delivery complex serves as a key component in drug delivery systems, enabling targeted delivery of various antigens and drugs to specific cells or organs. He has 1 patent to his name.

Career Highlights

Throughout his career, Katsuyuki Yui has been associated with notable institutions such as Nagasaki University and Kyushu University Corporation. His work at these universities has allowed him to explore and develop innovative solutions in the field of drug delivery.

Collaborations

Katsuyuki Yui has collaborated with esteemed colleagues, including Hitoshi Sasaki and Tomoaki Kurosaki. These partnerships have contributed to the advancement of research and development in his area of expertise.

Conclusion

Katsuyuki Yui's contributions to drug delivery systems exemplify the impact of innovative thinking in the medical field. His work continues to influence the development of effective treatment methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…